Release issued 16th April 2007

Porsolt & Partners Pharmacology has signed a co-marketing agreement with Maccine who provides contract services in pharmacology (safety and efficacy) in non-human primates.        

Under the terms of this agreement the two companies will promote their collective preclinical contract research service lines to the global pharmaceutical and biotech industry.    

For Porsolt & Partners Pharmacology, Dr Martine Lemaire, Senior Director of Scientific & Business Development explained: “ This strategic partnership will bring new and compelling synergies to our business . Providing a full package of flexible and tailored quality solutions is the key to satisfaction of our sponsors. Porsolt & Partners Pharmacology is committed to staying at the forefront of its field of acknowledged expertise and Maccine’s positioning with primate research will extend our range of services in pharmacology and enable us to better meet the needs of our sponsors ”.   Dr Mark Duxon, CEO of Maccine, commented on the move, “ We are delighted to be working alongside the leader in non-primate pharmacology services. Porsolt & Partners Pharmacology has over 20 years experience of safety and efficacy assessment in rodents, rabbits, ferrets, dogs and mini-pigs. Maccine’s safety and efficacy service portfolio in non-human primates is completely complementary , so this was a natural step .”    

“ In addition to widening our portfolio of procedures, this alliance with Maccine reinforces our long-term strategy of providing a worldwide service for our sponsors’ benefit ” said      Dr. Roger D. Porsolt, President of Porsolt & Partners Pharmacology.        

About Porsolt & Partners Pharmacology Porsolt & Partners Pharmacology is a French based Contract Research Organization providing specialized animal pharmacology research services (efficacy and safety) over a wide range of therapeutic domains.     For further information please contact: mlemaire@porsolt.com – www.porsolt.com    

About Maccine Maccine is a Singapore based preclinical Contract Research Organisation providing innovative discovery support and safety assessment services to the global biotech and pharma industry.   For further information please contact: media@maccine.com – www.maccine.com

(13th May 2009) Argenta Discovery and Porsolt Join Forces to Provide Fully-integrated CNS and Pain Contract Drug Discovery Services

(9th April 2009) Porsolt & Partners Pharmacology announces expansion of Operations and Global Business Development

(15th July 2008) Porsolt & Partners Pharmacology - Appointment of Dr. Mark Duxon as CEO